Current Panorama and Challenges for Neoadjuvant Cancer Immunotherapy
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-19-3255
Abstract: Immune checkpoint inhibitors (ICI) may overcome cancer cells' ability to evade the immune system and proliferate. The long-term benefit of ICI in the metastatic setting led to evaluate neoadjuvant ICI approaches in several tumor types… read more here.
Keywords: challenges neoadjuvant; panorama challenges; neoadjuvant ici; neoadjuvant cancer ... See more keywords